<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">09-PLGE-RA-0727R3</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1000697</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Replication and Repair</subject><subject>Genetics and Genomics/Gene Function</subject></subj-group></article-categories><title-group><article-title>Loss of Yeast Peroxiredoxin Tsa1p Induces Genome Instability through Activation of the DNA Damage Checkpoint and Elevation of dNTP Levels</article-title><alt-title alt-title-type="running-head">Loss of Peroxiredoxin Tsa1p Elevates dNTP Levels</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Hei-Man Vincent</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Siu</surname><given-names>Kam-Leung</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Chi-Ming</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Dong-Yan</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Biochemistry, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region, People's Republic of China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Cohen-Fix</surname><given-names>Orna</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">National Institute of Diabetes and Digestive and Kidney Diseases, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>wispwong@hkucc.hku.hk</email> (C-MW); <email>dyjin@hkucc.hku.hk</email> (D-YJ)</corresp><fn fn-type="con"><p>Conceived and designed the experiments: HMVT KLS CMW DYJ. Performed the experiments: HMVT KLS CMW. Analyzed the data: HMVT CMW DYJ. Wrote the paper: HMVT CMW DYJ.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>10</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>10</month><year>2009</year></pub-date><volume>5</volume><issue>10</issue><elocation-id>e1000697</elocation-id><history><date date-type="received"><day>1</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>23</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Tang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract><p>Peroxiredoxins are a family of antioxidant enzymes critically involved in cellular defense and signaling. Particularly, yeast peroxiredoxin Tsa1p is thought to play a role in the maintenance of genome integrity, but the underlying mechanism is not understood. In this study, we took a genetic approach to investigate the cause of genome instability in <italic>tsa1</italic>&#x00394; cells. Strong genetic interactions of <italic>TSA1</italic> with DNA damage checkpoint components <italic>DUN1</italic>, <italic>SML1</italic>, and <italic>CRT1</italic> were found when mutant cells were analyzed for either sensitivity to DNA damage or rate of spontaneous base substitutions. An elevation in intracellular dNTP production was observed in <italic>tsa1</italic>&#x00394; cells. This was associated with constitutive activation of the DNA damage checkpoint as indicated by phosphorylation of Rad9/Rad53p, reduced steady-state amount of Sml1p, and induction of <italic>RNR</italic> and <italic>HUG1</italic> genes. In addition, defects in the DNA damage checkpoint did not modulate intracellular level of reactive oxygen species, but suppressed the mutator phenotype of <italic>tsa1</italic>&#x00394; cells. On the contrary, overexpression of <italic>RNR1</italic> exacerbated this phenotype by increasing dNTP levels. Taken together, our findings uncover a new role of <italic>TSA1</italic> in preventing the overproduction of dNTPs, which is a root cause of genome instability.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Peroxiredoxins are a family of antioxidant enzymes highly conserved from yeast to human. Loss of peroxiredoxin in mice can lead to severe anemia and malignant tumors, but the underlying cause is not understood. One way to derive new knowledge of peroxiredoxins is through genetic analysis in yeast. We have shown that loss of peroxiredoxins in yeast is associated with an increase in mutation rates. Here, we demonstrate that this elevation of mutation rates in yeast cells lacking a peroxiredoxin is due to increased production of deoxyribonucleoside triphosphates (dNTPs), the building blocks of DNA. Our findings suggest a new model in which compromised antioxidant defense causes accumulation of damaged DNA and activation of the DNA damage checkpoint. For yeast cells to survive DNA damage, dNTP production is increased to facilitate DNA replication, but at the price of high mutation rates. This new model could lead to a better understanding of human diseases including cancer.</p></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Peroxiredoxins belong to a family of thiol-specific peroxidases widely and abundantly expressed in most living organisms <xref ref-type="bibr" rid="pgen.1000697-Rhee1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Fourquet1">&#x0005b;2&#x0005d;</xref>. Through one or more redox-sensitive cysteines, peroxiredoxins not only scavenge reactive oxygen species (ROS) including peroxides and peroxynitrite <xref ref-type="bibr" rid="pgen.1000697-Bryk1">&#x0005b;3&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Wong1">&#x0005b;4&#x0005d;</xref>, but also function as an ROS sensor to regulate cell signaling <xref ref-type="bibr" rid="pgen.1000697-Jin1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000697-Choi1">&#x0005b;11&#x0005d;</xref>. For many peroxiredoxins, another level of regulation can be achieved through oligomerization <xref ref-type="bibr" rid="pgen.1000697-Rhee1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Fourquet1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Lim1">&#x0005b;12&#x0005d;</xref>. In addition to their roles in peroxide reduction, peroxiredoxins are also known to possess chaperone activity <xref ref-type="bibr" rid="pgen.1000697-Lim1">&#x0005b;12&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Jang1">&#x0005b;13&#x0005d;</xref>.</p><p>Loss-of-function studies in mice implicated an essential role of peroxiredoxins in antioxidant defense and tumor suppression <xref ref-type="bibr" rid="pgen.1000697-Kmin1">&#x0005b;14&#x0005d;</xref>. Particularly, peroxiredoxin 1-knockout mice not only suffered from severe anemia due to oxidative stress, but were also susceptible to several types of malignant tumors <xref ref-type="bibr" rid="pgen.1000697-Neumann1">&#x0005b;15&#x0005d;</xref>. Consistent with this, genome-wide screening revealed that yeast peroxiredoxin <italic>TSA1</italic> was a strong suppressor of gross chromosomal rearrangements and spontaneous mutations <xref ref-type="bibr" rid="pgen.1000697-Huang1">&#x0005b;16&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Smith1">&#x0005b;17&#x0005d;</xref>. In addition, a mutator phenotype was observed in yeast cells lacking one or more peroxiredoxins. The phenotype could be rescued by yeast peroxiredoxin Tsa1p or mammalian Prx1, but not by their active-site mutants defective for peroxidase activity <xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Iraqui1">&#x0005b;19&#x0005d;</xref>. In further support of a role of <italic>TSA1</italic> in the maintenance of genome stability, many genetic interaction partners of <italic>TSA1</italic> identified through synthetic genetic array analysis were components of DNA repair machinery or DNA checkpoints <xref ref-type="bibr" rid="pgen.1000697-Tong1">&#x0005b;20&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Pan1">&#x0005b;21&#x0005d;</xref>. For example, <italic>TSA1</italic> was found to interact genetically with <italic>REV1</italic>/<italic>REV3</italic> and <italic>OGG1</italic>, which are critically involved in translesion synthesis (TLS) and the repair of oxidative DNA damage, respectively <xref ref-type="bibr" rid="pgen.1000697-Huang2">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>. However, the exact mechanism by which Tsa1p suppresses genome instability remains to be fully understood.</p><p>Intracellular dNTP levels are one important determinant of cellular response to DNA damage <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>. For yeast cells to survive DNA damage, increased dNTP production would be allowed to facilitate replication, but with a trade-off of high spontaneous mutation rate <xref ref-type="bibr" rid="pgen.1000697-Sabouri1">&#x0005b;25&#x0005d;</xref>. In other words, abnormally high dNTP levels are causally associated with genome instability <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Chabes2">&#x0005b;26&#x0005d;</xref>.</p><p>We previously demonstrated that yeast Tsa1p is a house-keeping peroxiredoxin which sufficiently suppressed the mutator phenotype <xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>. Although both an aberrantly high level of ROS and an imbalance in free radical contents, which is caused by compensational activation of other antioxidants such as Sod1p <xref ref-type="bibr" rid="pgen.1000697-Ogusucu1">&#x0005b;27&#x0005d;</xref>, could underlie the mutator phenotype of <italic>tsa1</italic>&#x00394; cells, additional events subsequent to the disruption of <italic>TSA1</italic> might also be influential in the induction of genome instability. In this study we asked whether perturbation of dNTP pools might contribute to the mutator phenotype observed in <italic>tsa1</italic>&#x00394; cells. We then investigated the cause of dNTP pool expansion. Our findings suggested that constitutive activation of the DNA damage checkpoint and consequent overproduction of dNTPs are the root cause of genome instability in <italic>tsa1&#x00394;</italic> cells.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Deletion of <italic>DUN1</italic>, <italic>SML1</italic>, or <italic>CRT1</italic> Modulates Sensitivity of <italic>tsa1</italic>&#x00394; Cells to DNA Damage</title><p>Yeast peroxiredoxin <italic>TSA1</italic> was found to be a strong suppressor of mutations and gross chromosomal rearrangements <xref ref-type="bibr" rid="pgen.1000697-Huang1">&#x0005b;16&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>. In addition, further deletion of another gene involved in DNA repair or DNA checkpoints caused synthetic growth defect or lethality in <italic>tsa1</italic>&#x00394; cells <xref ref-type="bibr" rid="pgen.1000697-Pan1">&#x0005b;21&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Huang2">&#x0005b;22&#x0005d;</xref>. Bearing these findings in mind, here we sought to dissect the interaction of <italic>TSA1</italic> with the DNA damage checkpoint and particularly the machinery of dNTP synthesis, in order to understand the role of <italic>TSA1</italic> in the maintenance of genome stability.</p><p>We first examined the sensitivity of <italic>tsa1</italic>&#x00394; cells to various DNA damaging agents. <italic>tsa1</italic>&#x00394; cells were sensitive to hydroxyurea (HU), 4-nitroquinoline 1-oxide (4NQO) and ultraviolet (UV) irradiation (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1A</xref>, lanes 1 and 5; <xref ref-type="fig" rid="pgen-1000697-g001">Figure 1B</xref>; <xref ref-type="fig" rid="pgen-1000697-g001">Figure 1C</xref> and <xref ref-type="fig" rid="pgen-1000697-g001">Figure 1D</xref>, lanes 1 and 2). Re-expression of <italic>TSA1</italic> in <italic>tsa1</italic>&#x00394; cells suppressed the sensitivity phenotype (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1C</xref> and <xref ref-type="fig" rid="pgen-1000697-g001">Figure 1D</xref>, lane 3). This suppression required the catalytic cysteine (Cys47) of Tsa1p, but not the C-terminal cysteine (Cys170), pointing to the importance of the antioxidant property of Tsa1p in the protection against DNA damage (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1C</xref>, lanes 3&#x02013;5).</p><fig id="pgen-1000697-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g001</object-id><label>Figure 1</label><caption><title>Influence of <italic>DUN1</italic>, <italic>SML1</italic>, or <italic>CRT1</italic> deletion on the sensitivity of <italic>tsa1</italic>&#x00394; cells to DNA damage and replicative stress.</title><p>(A) Spot tests. Ten-fold serial dilutions of strains BY4741 (<italic>WT</italic>), <italic>dun1</italic>&#x00394;, <italic>sml1</italic>&#x00394;, <italic>crt1</italic>&#x00394;, <italic>tsa1</italic>&#x00394;, <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394;, <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394;, and <italic>tsa1</italic>&#x00394; <italic>crt1</italic>&#x00394; were spotted on YPD medium containing indicated doses of H<sub>2</sub>O<sub>2</sub>, HU or 4-NQO. Cells were exposed to the indicated dose of UV after plating. Plates were incubated for 4 days at 30&#x000b0;C. Experiments were repeated for six times and similar results were obtained. (B) Survival curves. Logarithmically growing yeast cells, BY4741 (<italic>WT</italic>), <italic>dun1</italic>&#x00394;, <italic>sml1</italic>&#x00394;, <italic>tsa1</italic>&#x00394;, <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394;, and <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394;, in YPD were treated with indicated doses of 4-NQO for 90 min before plating on YPD agar. For UV treatment, cells were first plated onto YPD agar followed by UV irradiation at the indicated doses. Plates were incubated for 3 days at 30&#x000b0;C, and then counted for survival. The number of colonies from untreated plates was taken as 100&#x00025;. Experiments were repeated for three times and similar results were obtained. (C) <italic>TSA1</italic> catalytic cysteine mutant cannot complement the HU sensitivity in <italic>tsa1</italic>&#x00394; cells. Tenfold serial dilutions of the indicated strains transformed with pRS415, pTSA1, pTSA1C47S, or pTSA1C170S were spotted on SC-Leu plates containing 2&#x00025; glucose and the indicated doses of diamide or HU. Note that cells grew more slowly on SC plates than on YPD plates as shown in (A). (D) Influence of <italic>DUN1</italic>, <italic>SML1</italic>, or <italic>CRT1</italic> deletion on the sensitivity of <italic>sod1</italic>&#x00394; cells to DNA damage. (E) Complementation of drug sensitivity in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells by <italic>TSA1</italic> or <italic>DUN1</italic>.</p></caption><graphic xlink:href="pgen.1000697.g001"/></fig><p>The sensitivity of <italic>tsa1</italic>&#x00394; cells to DNA damage prompted us to investigate further the genetic interactions between <italic>TSA1</italic> and components of the DNA damage checkpoint. In light of the finding that <italic>TSA1</italic> genetically interacts with DNA damage checkpoint genes <italic>DUN1</italic> and <italic>SML1</italic><xref ref-type="bibr" rid="pgen.1000697-Huang2">&#x0005b;22&#x0005d;</xref>, we chose these two genes and their effector <italic>CRT1</italic> for further analysis. Dun1p is a checkpoint kinase that phosphorylates and regulates ribonucleotide reductase (RNR) inhibitor Sml1p <xref ref-type="bibr" rid="pgen.1000697-Zhao1">&#x0005b;28&#x0005d;</xref>. Dun1p also inhibits Crt1p, a transcriptional corepressor of RNR, through phosphorylation <xref ref-type="bibr" rid="pgen.1000697-Huang3">&#x0005b;29&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Zaim1">&#x0005b;30&#x0005d;</xref>. Deletion of <italic>DUN1</italic>, <italic>SML1</italic> or <italic>CRT1</italic> in <italic>tsa1</italic>&#x00394; cells exerted a significant impact on their sensitivity to HU, 4NQO and UV irradiation. Loss of <italic>DUN1</italic> further sensitized <italic>tsa1</italic>&#x00394; cells to H<sub>2</sub>O<sub>2</sub>, HU, 4NQO and UV (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1A</xref>, lanes 1, 2, 5 and 6). In support of the specificity of effect, this sensitization was reversed upon expression of <italic>TSA1</italic> or <italic>DUN1</italic> in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1D</xref>, lanes 6&#x02013;8). Conversely, loss of <italic>SML1</italic> or <italic>CRT1</italic> rescued the sensitivity phenotype of <italic>tsa1</italic>&#x00394; cells to 4NQO and UV (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1A</xref>, lanes 5, 7 and 8). It is noteworthy that such reversion of sensitivity was not observed in cells treated with H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1A</xref>, lanes 5, 7 and 8), suggesting that the effect might be specific to DNA damaging agents and was not caused directly by ROS. These observations supported the notion that <italic>TSA1</italic> interacts specifically with the DNA damage checkpoint in a manner that is not mediated directly through ROS.</p><p>Although the sensitivity pattern of the different mutant strains in the spot assay was highly reproducible, a more quantitative comparison of these strains is desired. Hence, survival curves of strains in the presence of 4NQO and UV were also obtained (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1B</xref>). Dose-dependent killing of the strains by 4NQO and UV was observed. At all doses tested, the degrees of sensitivity of different strains to either 4NQO or UV were in the same order as shown in the spot assay. In particular, the survival curves indicated a further enhancement of the sensitivity phenotype in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; versus <italic>tsa1</italic>&#x00394; cells and a suppression of sensitivity in <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1B</xref>). Collectively, our results demonstrated that the survival of <italic>tsa1</italic>&#x00394; cells under DNA damage was decreased upon deletion of <italic>DUN1</italic>, but enhanced when either <italic>SML1</italic> or <italic>CRT1</italic> was genetically disrupted.</p><p>We also compared the phenotypes of <italic>tsa1</italic>&#x00394; cells and cells lacking Sod1p, another key antioxidant enzyme <xref ref-type="bibr" rid="pgen.1000697-Carter1">&#x0005b;31&#x0005d;</xref>. In contrast to the genetic interactions observed in <italic>tsa1</italic>&#x00394; cells, deletion of <italic>DUN1</italic>, <italic>SML1</italic> or <italic>CRT1</italic> in <italic>sod1</italic>&#x00394; cells enhanced its sensitivity to HU and 4NQO (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1E</xref>, lanes 6, 7 and 8). Thus, <italic>TSA1</italic> and <italic>SOD1</italic> interact with <italic>DUN1</italic>, <italic>SML1</italic> and <italic>CRT1</italic> through different mechanisms.</p></sec><sec id="s2b"><title>Deletion of <italic>DUN1</italic>, <italic>SML1</italic>, or <italic>CRT1</italic> Modulates Mutator Phenotype of <italic>tsa1</italic>&#x00394; Cells</title><p>We next investigated whether compromising DNA damage checkpoint genes in <italic>tsa1</italic>&#x00394; cells might also alter their mutator phenotype. In agreement with previous reports <xref ref-type="bibr" rid="pgen.1000697-Huang1">&#x0005b;16&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>, <italic>tsa1</italic>&#x00394; cells exhibited high rates of spontaneous mutations in both canavanine-resistant (CAN<sup>R</sup>) and 5FC-resistant (5FC<sup>R</sup>) assays (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref>, <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 1 and 5). On the other hand, deletion of <italic>DUN1</italic> did not significantly affect spontaneous mutation rates (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref>, <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 1 and 2), whereas loss of <italic>SML1</italic> or <italic>CRT1</italic> caused a mild increase in CAN<sup>R</sup> mutation rates in WT cells (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 1, 3 and 4). However, the disruption of <italic>DUN1</italic>, <italic>SML1</italic> and <italic>CRT1</italic> in <italic>tsa1</italic>&#x00394; cells modulated the mutator phenotype in opposite directions (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref>, columns 5&#x02013;8). Whereas reduction of spontaneous mutation rates was observed in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref>, columns 5 and 6), deletion of <italic>SML1</italic> or <italic>CRT1</italic> in <italic>tsa1</italic>&#x00394; cells significantly enhanced the mutator phenotype (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref>, columns 1, 7 and 8). Complementation of the reduction of mutation rate in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells by re-introduction of <italic>DUN1</italic> or <italic>TSA1</italic> further verified the specificity of effect (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2C</xref>, columns 6 and 8). Thus, the mutation rates of <italic>tsa1</italic>&#x00394; cells correlated with the activity of the DNA damage checkpoint.</p><fig id="pgen-1000697-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g002</object-id><label>Figure 2</label><caption><title>Influence of <italic>DUN1</italic>, <italic>SML1</italic>, or <italic>CRT1</italic> deletion on the mutation rates of <italic>tsa1</italic>&#x00394; cells.</title><p>The number of CAN<sup>R</sup> (A) or 5FC<sup>R</sup> (B) colonies on synthetic complete solid medium either lacking arginine but containing CAN (60 mg/L) or supplemented with 5FC (100 mg/L) was normalized with the total number of viable cells grown on the same solid medium without CAN or 5FC. The relative mutation rate of BY4741 cells (WT) was taken as 1.00. <xref ref-type="sec" rid="s2">Results</xref> represent the average from triplicate analysis of ten independent cultures. (C) Complementation of mutator phenotype in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells by <italic>TSA1</italic> or <italic>DUN1</italic>. The rates of spontaneous CAN<sup>R</sup> mutation were calculated as in (A). (D) Influence of ROS on mutation rates. Cells of the indicated genotypes logarithmically growing in YPD were subjected to treatment of H<sub>2</sub>O<sub>2</sub> (0.6 mM, 15 min) before plating on synthetic complete solid medium lacking arginine and supplemented with CAN (60 mg/L). The rates of spontaneous CAN<sup>R</sup> mutation were calculated as in (A).</p></caption><graphic xlink:href="pgen.1000697.g002"/></fig><p>In all individual deletion mutants, <italic>tsa1</italic>&#x00394; cells displayed the highest mutation rate (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>). We postulated that this might be attributed either directly or indirectly to the elevation of intracellular ROS levels in these cells <xref ref-type="bibr" rid="pgen.1000697-Wong1">&#x0005b;4&#x0005d;</xref>. If that is the case, challenging the other DNA damage checkpoint mutants with ROS might have an impact on the mutator phenotype. To test this idea, we treated the cells with low-dose H<sub>2</sub>O<sub>2</sub> and assessed the impact on CAN<sup>R</sup> mutation rates. Interestingly, mutation rates increased in WT and <italic>dun1</italic>&#x00394; cells to comparable levels (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 1 and 2). In contrast, a further increase in mutability was observed when <italic>SML1</italic> or <italic>CRT1</italic> was comprised (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 1, 3 and 4). Although the mutation rates of <italic>sml1</italic>&#x00394; and <italic>crt1</italic>&#x00394; cells in the presence of H<sub>2</sub>O<sub>2</sub> were still not as high as that of <italic>tsa1</italic>&#x00394; cells in the absence of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>, groups 3&#x02013;5), our results did suggest that ROS could differentially modulate the mutator phenotype of different mutants.</p></sec><sec id="s2c"><title>Loss of <italic>TSA1</italic> Elevates Cellular dNTP Production</title><p>We next investigated the mechanism that underlies the correlation of DNA damage checkpoint activity in <italic>tsa1</italic>&#x00394; cells with drug sensitivity and mutator phenotype (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>). <italic>DUN1</italic>, <italic>SML1</italic> and <italic>CRT1</italic> are regulators of RNR, the rate-limiting enzyme in dNTP synthesis <xref ref-type="bibr" rid="pgen.1000697-Elledge1">&#x0005b;32&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000697-Nordlund1">&#x0005b;34&#x0005d;</xref>. Considered together with the model that elevated dNTP levels are required for surviving DNA damage in yeast at the price of increasing mutation rates <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>, we asked whether the mutator phenotype of <italic>tsa1</italic>&#x00394; cells would be due to alteration in cellular dNTP production. Thus, we measured dNTP levels in our mutants. Surprisingly, <italic>tsa1</italic>&#x00394; cells produced significantly more dNTPs than wild type (WT) cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 1 and 5). The magnitude of dNTP overproduction in <italic>tsa1</italic>&#x00394; cells was comparable to that in <italic>sml1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 3 and 5), in which the removal of Sml1p activates RNR leading to the rise in dNTP levels <xref ref-type="bibr" rid="pgen.1000697-Zhao1">&#x0005b;28&#x0005d;</xref>.</p><fig id="pgen-1000697-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g003</object-id><label>Figure 3</label><caption><title>dNTP levels of <italic>tsa1</italic>&#x00394; cells and influence of <italic>DUN1</italic>, <italic>SML1</italic>, and <italic>CRT1</italic> deletion.</title><p>(A) Comparison of dNTP levels. Relative dNTP levels were determined in the indicated strains of cells growing logarithmically. (B) Suppression of dNTP pool phenotype by <italic>TSA1</italic>. Assays were done with WT and <italic>tsa1</italic>&#x00394; strains transformed with pRS415, pTSA1, or pTSA1C47S. (C) ROS detection. Cells of the indicated strains logarithmically growing in YPD were subjected to treatment with DCF (10 &#x000b5;M, 45 min). Crude extracts of cells were subjected to DCF fluorescence measurement on an F-4500 spectrofluorimeter (Hitachi). The excitation and emission wavelengths were 488 and 520 nm, respectively. The reading of DCF fluorescence was normalized to protein concentration. The fluorescent intensity of BY4741 cells (WT) was taken as 1. <xref ref-type="sec" rid="s2">Results</xref> represent the average from three independent experiments.</p></caption><graphic xlink:href="pgen.1000697.g003"/></fig><p>To shed further light on the roles of dNTP production in the generation of mutator phenotype, we compared the dNTP levels in other mutant cells. As expected, <italic>dun1</italic>&#x00394; cells produced less dNTPs than WT cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 1 and 2), since Dun1p is required for phosphorylation and subsequent removal of the RNR inhibitor Sml1p <xref ref-type="bibr" rid="pgen.1000697-Zhao1">&#x0005b;28&#x0005d;</xref>. Loss of <italic>CRT1</italic> was also found to increase cellular dNTP production (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 1 and 4), as Crt1p is a transcriptional corepressor of RNRs <xref ref-type="bibr" rid="pgen.1000697-Huang3">&#x0005b;29&#x0005d;</xref>. However, loss of <italic>DUN1</italic> reduced cellular dNTP production in <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 5 and 6), whereas deletion of <italic>SML1</italic> or <italic>CRT1</italic> in <italic>tsa1</italic>&#x00394; cells further increased dNTP levels (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 5, 7 and 8). Noteworthily, increased production of dNTPs in <italic>tsa1</italic>&#x00394; cells could be fully complemented by Tsa1p, but not by its catalytic cysteine mutant C47S (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3B</xref>). Thus, the antioxidant property of Tsa1p was likely required for preventing overproduction of dNTPs.</p><p>We then asked whether the reduction of dNTP pools in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells would be associated with a further drop in intracellular ROS levels in the absence of <italic>DUN1</italic>. Interestingly, <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells exhibited a higher level of intracellular ROS over WT, <italic>tsa1</italic>&#x00394; or <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>, columns 1, 2, 5 and 6), suggesting that the mutator phenotype in <italic>tsa1</italic>&#x00394; and <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells correlates directly with dNTP production, but not generation of ROS. On the other hand, loss of <italic>SML1</italic> or <italic>CRT1</italic> did not alter the ROS levels in either WT or <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>, columns 1, 3, 4, 5, 7 and 8). Thus, in addition to the accumulation of ROS, elevation of dNTP production might also contribute to genome instability in <italic>tsa1</italic>&#x00394; cells.</p><p>While deletion of <italic>DUN1</italic>, <italic>SML1</italic> or <italic>CRT1</italic> has an impact on dNTP production, they are multifunctional proteins that might also affect other biological processes <xref ref-type="bibr" rid="pgen.1000697-Zhao1">&#x0005b;28&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pgen.1000697-Zaim1">&#x0005b;30&#x0005d;</xref>. To address this concern, we modulated the production of dNTP more directly by overexpressing <italic>RNR1</italic> gene in <italic>tsa1</italic>&#x00394; and <italic>sod1</italic>&#x00394; cells. This overexpression has previously been shown to elevate intracellular dNTP levels substantially <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Chabes2">&#x0005b;26&#x0005d;</xref>. Indeed, when we induced the expression of Rnr1-3MYCp in WT cells (<xref ref-type="fig" rid="pgen-1000697-g004">Figure 4A</xref>), the spontaneous mutation rate was increased (<xref ref-type="fig" rid="pgen-1000697-g004">Figure 4B</xref>, columns 1 and 2). Furthermore, overexpression of RNR1 also exacerbated the mutator phenotype in <italic>tsa1</italic>&#x00394; and <italic>sod1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g004">Figure 4B</xref>, columns 3&#x02013;6). This lent additional support to the importance of dNTP overproduction in the induction of genome instability.</p><fig id="pgen-1000697-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g004</object-id><label>Figure 4</label><caption><title>Overexpression of <italic>RNR1</italic> enhances mutator phenotype of <italic>tsa1</italic>&#x00394; cells.</title><p>BY4741 (<italic>WT</italic>), <italic>sod1</italic>&#x00394;, and <italic>tsa1</italic>&#x00394; cells carrying plasmid pGal-RNR1 were grown in SC-Ura medium supplemented with raffinose (uninduced) or galactose (induced) to mid-log phase. (A) Galactose-induced expression of Rnr1-3MYCp. Western blotting was performed with mouse anti-MYC (Roche) and mouse anti-Pgk1p (Invitrogen) antibodies. (B) Mutation rates. Experiments were carried out as in <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>.</p></caption><graphic xlink:href="pgen.1000697.g004"/></fig><p>If the mutability of <italic>tsa1</italic>&#x00394; cells is indeed caused by dNTP overproduction, the mutations generated would primarily be base substitutions rather than large deletion and gross chromosomal rearrangements <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>. With this in mind, we examined the types of mutations arisen in <italic>tsa1</italic>&#x00394; and other mutants (<xref ref-type="table" rid="pgen-1000697-t001">Table 1</xref>). We noted that the majority of mutations found in <italic>tsa1</italic>&#x00394; cells were base substitutions (83.3&#x00025;) and frameshifts (13.3&#x00025;). Large deletions were very rare in <italic>tsa1</italic>&#x00394; cells (3.3&#x00025;) when compared with WT (13.3&#x00025;) cells. In addition, all of the mutations found in <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394; cells with high dNTP levels (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>) were base substitutions (90&#x00025;) and frameshifts (10&#x00025;), whereas more deletions (13.3&#x00025;) were detected in <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells (<xref ref-type="table" rid="pgen-1000697-t001">Table 1</xref>) with low dNTP concentrations (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). In keeping with previous findings <xref ref-type="bibr" rid="pgen.1000697-Huang1">&#x0005b;16&#x0005d;</xref>, relatively more deletions (10&#x00025;) were also observed in <italic>sod1</italic>&#x00394; cells (<xref ref-type="table" rid="pgen-1000697-t001">Table 1</xref>). Generally, base substitutions were more prevalent in the strain when dNTP levels were high (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>), whereas the incidences of deletions correlated negatively with dNTP concentrations. Therefore, the mutation spectra of <italic>tsa1</italic>&#x00394; and other strains are consistent with the notion that elevation of dNTP levels is the underlying cause of genome instability in the absence of <italic>TSA1</italic>.</p><table-wrap id="pgen-1000697-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.t001</object-id><label>Table 1</label><caption><title>Spectra and rates of CAN<sup>R</sup> mutations in <italic>tsa1</italic>&#x00394; and <italic>sod1</italic>&#x00394; strains.</title></caption><alternatives><graphic id="pgen-1000697-t001-1" xlink:href="pgen.1000697.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">strain</td><td align="left" rowspan="1" colspan="1">type of mutation</td><td align="left" rowspan="1" colspan="1">frequency (&#x00025;)</td><td align="left" rowspan="1" colspan="1">mutation rate (&#x000d7;10<sup>&#x02212;7</sup>)</td><td align="left" rowspan="1" colspan="1">specific mutation rate (&#x000d7;10<sup>&#x02212;7</sup>)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>wild type</bold></td><td align="left" rowspan="1" colspan="1"><bold>base substitution</bold></td><td align="left" rowspan="1" colspan="1"><bold>18/30 (60.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1">3.1</td><td align="left" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transversion</td><td align="left" rowspan="1" colspan="1">10/30 (33.3&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transition</td><td align="left" rowspan="1" colspan="1">8/30 (26.7&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>frameshift</bold></td><td align="left" rowspan="1" colspan="1"><bold>5/30 (16.7&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>large deletion</bold></td><td align="left" rowspan="1" colspan="1"><bold>3/30 (10.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>complex</bold></td><td align="left" rowspan="1" colspan="1"><bold>4/30 (13.3&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>tsa1</italic></bold>&#x00394;</td><td align="left" rowspan="1" colspan="1"><bold>base substitution</bold></td><td align="left" rowspan="1" colspan="1"><bold>25/30 (83.3&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1">62.5</td><td align="left" rowspan="1" colspan="1">52.0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transversion</td><td align="left" rowspan="1" colspan="1">15/30 (50.0&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">31.2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transition</td><td align="left" rowspan="1" colspan="1">10/30 (33.3&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">20.8</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>frameshift</bold></td><td align="left" rowspan="1" colspan="1"><bold>4/30 (13.3&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>large deletion</bold></td><td align="left" rowspan="1" colspan="1"><bold>1/30 (3.3&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>tsa1</italic></bold>&#x00394;<bold><italic>dun1</italic></bold>&#x00394;</td><td align="left" rowspan="1" colspan="1"><bold>base substitution</bold></td><td align="left" rowspan="1" colspan="1"><bold>24/30 (80.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1">35.5</td><td align="left" rowspan="1" colspan="1">28.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transversion</td><td align="left" rowspan="1" colspan="1">14/30 (46.7&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">16.6</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transition</td><td align="left" rowspan="1" colspan="1">10/30 (33.3&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11.8</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>frameshift</bold></td><td align="left" rowspan="1" colspan="1"><bold>2/30 (6.7&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>3 bp deletion</bold></td><td align="left" rowspan="1" colspan="1"><bold>1/30 (3.3&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>large deletion</bold></td><td align="left" rowspan="1" colspan="1"><bold>3/30 (10.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.6</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>tsa1</italic></bold>&#x00394;<bold><italic>sml1</italic></bold>&#x00394;</td><td align="left" rowspan="1" colspan="1"><bold>base substitution</bold></td><td align="left" rowspan="1" colspan="1"><bold>27/30 (90.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1">143.3</td><td align="left" rowspan="1" colspan="1">129.0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transversion</td><td align="left" rowspan="1" colspan="1">15/30 (50.0&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">71.7</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transition</td><td align="left" rowspan="1" colspan="1">12/30 (40.0&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">57.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>frameshift</bold></td><td align="left" rowspan="1" colspan="1"><bold>3/30 (10.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">14.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><italic>sod1</italic></bold>&#x00394;</td><td align="left" rowspan="1" colspan="1"><bold>base substitution</bold></td><td align="left" rowspan="1" colspan="1"><bold>24/30 (80.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1">33.9</td><td align="left" rowspan="1" colspan="1">27.1</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transversion</td><td align="left" rowspan="1" colspan="1">14/30 (46.7&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">15.8</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">transition</td><td align="left" rowspan="1" colspan="1">10/30 (33.3&#x00025;)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11.3</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>frameshift</bold></td><td align="left" rowspan="1" colspan="1"><bold>3/30 (10.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.4</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>large deletion</bold></td><td align="left" rowspan="1" colspan="1"><bold>3/30 (10.0&#x00025;)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.4</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><p>Mutation rates are calculated from three independent experiments, each with ten cultures. Variations are within 15&#x00025; of the values.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2d"><title>Loss of <italic>TSA1</italic> Activates DNA Damage Checkpoint Leading to Elevation in dNTP Production</title><p>Above we demonstrated the elevation of dNTP levels in <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). In addition, our results also indicated the genetic interaction of <italic>TSA1</italic> with DNA checkpoint genes (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref>). This led us to further investigate whether elevated production of dNTPs in the absence of <italic>TSA1</italic> might be explained by the activation of the DNA damage checkpoint. As a first step, we assessed checkpoint activation by examining the steady-state levels of Rad53p, the yeast ortholog of human CHK2 kinase whose phosphorylation and activation are pivotally involved in the control of checkpoint response to DNA damage <xref ref-type="bibr" rid="pgen.1000697-Sanchez1">&#x0005b;35&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Pellicioli1">&#x0005b;36&#x0005d;</xref>. Particularly, Rad53p is a master regulator of Dun1p, Sml1p and Crt1p <xref ref-type="bibr" rid="pgen.1000697-Sanchez1">&#x0005b;35&#x0005d;</xref>.</p><p>In this analysis we included the <italic>sod1</italic>&#x00394; control strain, in which the effectors of the Mec1p-dependent DNA damage checkpoint were previously shown to be downregulated <xref ref-type="bibr" rid="pgen.1000697-Carter1">&#x0005b;31&#x0005d;</xref>. Phosphorylated Rad53p species were more evident in <italic>tsa1</italic>&#x00394; cells compared to WT and <italic>sod1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5A</xref>, lanes 1, 3 and 5; <xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 1 and 2; <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6A</xref>, lanes 1 and 2; and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lanes 1 and 3). This difference became more pronounced in the presence of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5A</xref>, lanes 2, 4 and 6; <xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 5 and 6; <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6A</xref>, lanes 3 and 4; and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lanes 5 and 7).</p><fig id="pgen-1000697-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g005</object-id><label>Figure 5</label><caption><title>Activation of DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells.</title><p>(A) Western blot analysis of Rad53p. Cells of WT, <italic>sod1</italic>&#x00394;, and <italic>tsa1</italic>&#x00394; strains logarithmically growing in YPD were subjected to treatment with H<sub>2</sub>O<sub>2</sub> (0.8 mM, 30 min). Western blotting was performed with goat anti-Rad53p (Santa-Cruz) and mouse anti-Pgk1p antibodies. Percentages of phosphorylated Rad53p were determined by densitometry and indicated at the bottom of the panel. (B) <italic>TSA1</italic> complementation assay. WT and <italic>tsa1</italic>&#x00394; cells were transformed with pRS415, pTSA1, or pTSA1C47S plasmid. Western blotting was carried out with goat anti-Rad53p, mouse anti-HA (Santa-Cruz), rabbit anti-histone H2A phosphorylated at S129 (&#x003b3;H2A; Abcam), and mouse anti-Pgk1p antibodies. Relative amounts of Sml1-3HAp or &#x003b3;H2A normalized to Pgk1p were determined by densitometry and indicated at the bottom of the panels. (C) Checkpoint activation in different strains.</p></caption><graphic xlink:href="pgen.1000697.g005"/></fig><fig id="pgen-1000697-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g006</object-id><label>Figure 6</label><caption><title>Activation of DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells.</title><p>(A) Western blot analysis of Rad53p. Cells of the indicated strains in W303 background logarithmically growing in YPD were subjected to treatment with H<sub>2</sub>O<sub>2</sub> (0.8 mM, 30 min). (B) Western blot analysis of Rad9p in <italic>tsa1</italic>&#x00394; and <italic>TSA1</italic>-complemented strains. A longer exposure (long exp.) of the Rad9p blot was also shown. (C) Semi-quantitative RT&#x02013;PCR analysis of <italic>RNR</italic> transcripts. Logarithmically growing cells of the indicated strains in YPD were subjected to treatment with HU (200 mM) at the indicated time points. Total RNA was extracted and 3 &#x000b5;g of RNA was used for cDNA synthesis. PCR was performed to assess the levels of <italic>RNR1/2/3/4</italic>, <italic>HUG1</italic>, and <italic>ACT1</italic> transcripts. The expected sizes of the PCR product for <italic>RNR1</italic>, <italic>RNR2</italic>, <italic>RNR3</italic>, <italic>RNR4</italic>, <italic>ACT1</italic>, and <italic>HUG1</italic> are 219, 390, 199, 455, 520, and 190 bp, respectively. Relative levels of RNA determined by densitometry and normalized to the amount of <italic>ACT1</italic> transcript were indicated at the bottom of the panels.</p></caption><graphic xlink:href="pgen.1000697.g006"/></fig><fig id="pgen-1000697-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.g007</object-id><label>Figure 7</label><caption><title>Impact of <italic>RAD53</italic> mutation on <italic>tsa1</italic>&#x00394; cells.</title><p>(A) Western blot analysis of Rad53p and Sml1-3HAp. Cells of the indicated strains in W303 background logarithmically growing in YPD were subjected to treatment with H<sub>2</sub>O<sub>2</sub> (0.8 mM, 30 min). Western blotting was performed as in <xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>. (B) Spot assay. Ten-fold serial dilutions of the indicated strains were spotted on YPD medium containing the indicated doses of H<sub>2</sub>O<sub>2</sub> or HU. Some cells were exposed to UV after plating. (C) <italic>RAD53</italic> mutation suppresses mutator phenotype in <italic>tsa1</italic>&#x00394; cells. Mutation rates were calculated as in <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref>. (D) ROS detection. DCF fluorescence was measured as in <xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>.</p></caption><graphic xlink:href="pgen.1000697.g007"/></fig><p>The steady-state levels of phosphorylated Rad53p in DNA damage checkpoint mutants were also compared. Whereas deletion of <italic>DUN1</italic> triggered phosphorylation of Rad53p (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 1 and 2), an observable increase in phosphorylated Rad53p species was not found in <italic>sml1</italic>&#x00394; or <italic>crt1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 1, 3 and 4). Notably, loss of <italic>DUN1</italic> in <italic>tsa1</italic>&#x00394; cells further enhanced the activation of Rad53p (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 5 and 6), whereas <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394; and <italic>tsa1</italic>&#x00394; <italic>crt1</italic>&#x00394; cells had similar levels of phosphorylated Rad53p compared to tsa1&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 5, 7 and 8).</p><p>In addition to Rad53p, we also checked for the status of Rad9p, a more upstream transducer in the DNA damage checkpoint pathway <xref ref-type="bibr" rid="pgen.1000697-Sweeney1">&#x0005b;37&#x0005d;</xref>. Rad9-13MYCp was found to be activated in <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6B</xref>, lanes 1, 2, 4 and 5) and this activation could not be reversed by the C47S mutant of Tsa1p (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6B</xref>, lanes 2, 3, 5 and 6). As a marker for DNA double-strand breaks (DSBs) <xref ref-type="bibr" rid="pgen.1000697-Fillingham1">&#x0005b;38&#x0005d;</xref>, the level of &#x003b3;H2A was also found to be elevated in <italic>tsa1</italic>&#x00394; cells as compared to WT (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 1 and 2; <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6A</xref>, lanes 1 and 2; and <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6B</xref>, lanes 1 and 2). This agrees with a recent report that <italic>tsa1</italic>&#x00394; cells displayed an increased number of Rad52-YFP foci indicative of DNA damage <xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>. The levels of &#x003b3;H2A in other DNA damage checkpoint mutant cells were also examined. Among <italic>dun1</italic>&#x00394;, <italic>sml1</italic>&#x00394; and <italic>crt1</italic>&#x00394; cells, an elevation in &#x003b3;H2A level was only found in <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lane 2). In addition, disruption of <italic>DUN1</italic>, <italic>SML1</italic> or <italic>CRT1</italic> in <italic>tsa1</italic>&#x00394; cells did not affect &#x003b3;H2A levels significantly (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 5&#x02013;8). Noteworthily, although phosphorylated Rad53p and &#x003b3;H2A were abundant in <italic>dun1</italic>&#x00394; and <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>, lanes 2 and 6), their mutation rates remained low (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2A</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2B</xref>, columns 2 and 6) plausibly due to the low levels of dNTPs (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>, groups 2 and 6). In other words, elevation of dNTP levels might be the direct cause of genome instability.</p><p>Consistent with the activation of Rad53p and Rad9p, the levels of Rad53p target Sml1-3HAp were diminished in <italic>tsa1</italic>&#x00394; cells in the presence (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 5 and 6) and absence of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 1 and 2). Importantly, all of the above changes in <italic>tsa1</italic>&#x00394; cells could be fully complemented by <italic>TSA1</italic> (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 2 and 3), but not by its C47S mutant (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5B</xref>, lanes 2 and 4). On the other hand, in agreement with previous findings <xref ref-type="bibr" rid="pgen.1000697-Carter1">&#x0005b;31&#x0005d;</xref>, we did not observe a significant change of Sml1p level in <italic>sod1</italic>&#x00394; cells (data not shown).</p><p>RNR is an important downstream effector of the DNA damage checkpoint which mediates the production of dNTPs <xref ref-type="bibr" rid="pgen.1000697-Gon1">&#x0005b;33&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Nordlund1">&#x0005b;34&#x0005d;</xref>. Since the expression of <italic>RNR</italic> genes is transcriptionally activated in response to DNA damage <xref ref-type="bibr" rid="pgen.1000697-Huang3">&#x0005b;29&#x0005d;</xref>, we used semi-quantitative RT-PCR to determine the relative levels of <italic>RNR1/2/3/4</italic> transcripts in the presence and absence of HU. In this analysis we included an additional control termed <italic>HUG1</italic>, a target of Mec1p induced highly by DNA damage <xref ref-type="bibr" rid="pgen.1000697-Basrai1">&#x0005b;39&#x0005d;</xref>. As shown in <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6C</xref>, <italic>RNR</italic> transcripts were induced to higher levels in <italic>tsa1</italic>&#x00394; cells than in WT and <italic>sod1</italic>&#x00394; cells. The induction of <italic>RNR1</italic> and <italic>RNR3</italic> was greatest in both untreated and HU-treated <italic>tsa1</italic>&#x00394; cells. The level of <italic>HUG1</italic> transcript was also elevated in <italic>tsa1</italic>&#x00394; cells and this was more pronounced in the presence of HU (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6C</xref>). In sharp contrast, <italic>sod1</italic>&#x00394; cells treated with HU showed a lower magnitude of induction of <italic>RNR1</italic>, <italic>RNR3</italic> and <italic>HUG1</italic> mRNAs (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6C</xref>). These results obtained from <italic>sod1</italic>&#x00394; cells were generally consistent with previous findings <xref ref-type="bibr" rid="pgen.1000697-Carter1">&#x0005b;31&#x0005d;</xref>. Thus, the pattern of <italic>RNR</italic> induction in <italic>tsa1</italic>&#x00394; cells was not ascribed to a general effect caused by the lack of any antioxidant enzyme, but was highly specific. Collectively, our results suggested that loss of <italic>TSA1</italic> induces the activation of the DNA damage checkpoint leading to the induction of RNR and consequent overproduction of dNTPs.</p></sec><sec id="s2e"><title>Mutation of Rad53p Suppresses Genome Instability in <italic>tsa1</italic>&#x00394; Cells</title><p>If activation of the DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells is really important to the generation of genome instability caused by dNTP overproduction, genetic disruption of the checkpoint would be able to reverse the mutator phenotype of <italic>tsa1</italic>&#x00394; cells.</p><p>To test this hypothesis, we employed a <italic>RAD53</italic> mutant termed <italic>rad53AA</italic>, in which both T354 and T358 in the activation loop of Rad53p had been replaced by alanine, thereby abrogating the autophosphorylation activity in response to DNA damage <xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref>. This defective <italic>rad53AA</italic> allele similar to <italic>rad53-11</italic> is thought to be associated with reduced dNTP production due to high abundance of Sml1p <xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Koc1">&#x0005b;41&#x0005d;</xref>. Thus, we set out to characterize the phenotypes of <italic>tsa1</italic>&#x00394; cells carrying the <italic>rad53AA</italic> allele.</p><p>As documented previously <xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref>, <italic>TSA1 rad53AA</italic> cells exhibited lower levels of phosphorylated Rad53p and higher abundance of Sml1-3HAp than <italic>TSA1 RAD53</italic> cells (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lanes 1, 2, 5 and 6). In response to H<sub>2</sub>O<sub>2</sub>, &#x003b3;H2A was induced to higher levels in all mutant cells (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lanes 5&#x02013;8 compared to lanes 1&#x02013;4). Notably, both <italic>tsa1</italic>&#x00394; <italic>RAD53</italic> and <italic>tsa1</italic>&#x00394; <italic>rad53AA</italic> cells showed similar basal levels of &#x003b3;H2A (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lanes 3 and 4). Although stronger Rad53p activation was observed in <italic>tsa1</italic>&#x00394; <italic>rad53AA</italic> cells, a more pronounced Sml1-3HAp protein band was seen (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>, lane 4 compared to lane 3), suggestive of a defective DNA damage checkpoint.</p><p>We next characterized the sensitivity of these mutants towards H<sub>2</sub>O<sub>2</sub>, UV and HU. <italic>TSA1 rad53AA</italic> cells were sensitive to HU (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7B</xref>, lanes 1 and 2) as previously described <xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref>; while <italic>tsa1</italic>&#x00394; <italic>RAD53</italic> cells were sensitive to H<sub>2</sub>O<sub>2</sub>, UV and HU (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7B</xref>, lanes 1 and 3) similar to <italic>tsa1</italic>&#x00394; cells in BY4741 background (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref>, lanes 1 and 5). Resembling <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells in BY4741, <italic>tsa1</italic>&#x00394; <italic>rad53AA</italic> cells in W303 background displayed further sensitivity to H<sub>2</sub>O<sub>2</sub> and UV when compared to <italic>tsa1</italic>&#x00394; <italic>RAD53</italic> cells (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7B</xref>, lanes 3 and 4).</p><p>We then looked at the effect of a defective DNA damage checkpoint on genome instability in <italic>tsa1</italic>&#x00394; cells. Intriguingly, <italic>tsa1</italic>&#x00394; <italic>rad53AA</italic> cells displayed a significantly reduced (&#x0223c;50&#x00025;) rate of spontaneous 5FC<sup>R</sup> mutations over <italic>tsa1</italic>&#x00394; <italic>RAD53</italic> cells (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7C</xref>). On the other hand, both <italic>tsa1</italic>&#x00394; <italic>rad53AA</italic> and <italic>tsa1</italic>&#x00394; <italic>RAD53</italic> cells had high levels of intracellular ROS over WT cells as measured by DCF fluorescence (<xref ref-type="fig" rid="pgen-1000697-g007">Figure 7D</xref>). These observations suggested that <italic>rad53AA</italic> mutation can suppress the mutator phenotype in <italic>tsa1</italic>&#x00394; cells without affecting cellular redox environment. This generally agrees with the phenotypes of <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref> and <xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>), lending further support to the concept that intracellular dNTP levels are an important determinant in the induction of genome instability in <italic>tsa1</italic>&#x00394; cells.</p></sec></sec><sec id="s3"><title>Discussion</title><p>Here, we provided the first evidence that loss of yeast peroxiredoxin <italic>TSA1</italic> causes genome instability through constitutive activation of the DNA damage checkpoint leading to overproduction of intracellular dNTPs. There are two salient points in our work. First, we demonstrated the elevation of dNTP levels in <italic>tsa1</italic>&#x00394; cells and its direct correlation with the mutator phenotype (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>, <xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>, <xref ref-type="fig" rid="pgen-1000697-g004">Figure 4</xref>). Second, we demonstrated the activation of the DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells in relation to elevated production of dNTPs (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref>, <xref ref-type="fig" rid="pgen-1000697-g005">Figure 5</xref>, <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6</xref>, <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7</xref>). Our findings suggested a new model for the role of peroxiredoxins in the maintenance of genome integrity, which has implications in the understanding of human diseases including cancer.</p><p>In agreement with our findings on the accumulation of &#x003b3;H2A and activation of the DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells, several lines of evidence in the literature supported the role of Tsa1p and other peroxiredoxins in the protection of cells against DNA damage. First, <italic>tsa1</italic>&#x00394; cells produce significantly more ROS <xref ref-type="bibr" rid="pgen.1000697-Wong1">&#x0005b;4&#x0005d;</xref>, which cause DNA and protein damage <xref ref-type="bibr" rid="pgen.1000697-Ogusucu1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Beckman1">&#x0005b;42&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Finkel1">&#x0005b;43&#x0005d;</xref>. Second, loss of <italic>TSA1</italic> results in increased formation of Rad52-YFP foci, an indicator of DNA DSBs <xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>. Third, <italic>tsa1</italic>&#x00394; cells are highly sensitive to the functional state of DNA repair and checkpoints <xref ref-type="bibr" rid="pgen.1000697-Huang2">&#x0005b;22&#x0005d;</xref>. In particular, <italic>tsa1</italic>&#x00394; is synthetically lethal with <italic>rad51</italic>&#x00394; mutation, indicating that the viability of <italic>rad51</italic>&#x00394; cells deficient in recombination repair requires <italic>TSA1</italic> function <xref ref-type="bibr" rid="pgen.1000697-Iraqui2">&#x0005b;44&#x0005d;</xref>. Finally, human peroxiredoxins have been implicated in cellular defense against oxidative DNA lesions <xref ref-type="bibr" rid="pgen.1000697-Graves1">&#x0005b;45&#x0005d;</xref>. In this context, the activation of the DNA damage checkpoint in <italic>tsa1</italic>&#x00394; cells demonstrated in our study highlights the pivotal roles of the checkpoint in cell survival and provides an explanation for the synthetic lethality seen in various double deletion mutants involving <italic>TSA1</italic> and another DNA repair or checkpoint gene <xref ref-type="bibr" rid="pgen.1000697-Pan1">&#x0005b;21&#x0005d;</xref>.</p><p>Deletion of <italic>TSA1</italic> in yeast cells has previously been shown to result in both a mutator phenotype and an increase in gross chromosomal rearrangements <xref ref-type="bibr" rid="pgen.1000697-Huang1">&#x0005b;16&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Huang2">&#x0005b;22&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>. Although the causes and origin of gross chromosomal rearrangements remain poorly understood, oxygen metabolism and ROS production are implicated in the prevalence of these rearrangements in <italic>tsa1</italic>&#x00394; cells <xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>. Noteworthily, base substitution, but not chromosomal rearrangement, was the predominant type of mutation found in our analysis of mutation rates (<xref ref-type="table" rid="pgen-1000697-t001">Table 1</xref>). Thus, the major type of genome instability analyzed in our study is an increased rate of point mutations, but not gross chromosomal rearrangements involving more complex alterations such as translocations, large deletions and amplifications.</p><p>Our findings point to a role of dNTP levels in determining the mutation rate of <italic>tsa1</italic>&#x00394; cells. Strong genetic interactions between <italic>TSA1</italic> and four RNR regulators <italic>DUN1</italic>, <italic>SML1</italic>, <italic>CRT1</italic> and <italic>RAD53</italic> were observed in the context of sensitivity to DNA damage (<xref ref-type="fig" rid="pgen-1000697-g001">Figure 1</xref> and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7</xref>), spontaneous mutability (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref> and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7</xref>) and dNTP production (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). Although the catalytic cysteine of Tsa1p is required for the suppression of mutator phenotype, the mutability of <italic>tsa1</italic>&#x00394; cells correlated directly with dNTP concentrations (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>, <xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>, <xref ref-type="fig" rid="pgen-1000697-g004">Figure 4</xref>), but not with high ROS levels (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref> and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7</xref>). One plausible explanation is that the loss of <italic>TSA1</italic> might cause accumulation of both ROS <xref ref-type="bibr" rid="pgen.1000697-Wong1">&#x0005b;4&#x0005d;</xref> and DNA damage (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5</xref>). This activates the DNA damage checkpoint through Rad53p, Rad9p and Sml1p (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5</xref>, <xref ref-type="fig" rid="pgen-1000697-g006">Figure 6</xref>, <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7</xref>) leading to transcriptional activation of RNR genes (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6</xref>) and elevated production of dNTPs (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). Once at high dNTP levels, replicative and TLS polymerases by-pass DNA lesions more efficiently to promote survival, but only at the price of increasing mutation rates <xref ref-type="bibr" rid="pgen.1000697-Chabes1">&#x0005b;24&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Sabouri1">&#x0005b;25&#x0005d;</xref>. This model implicates dNTP pool expansion as the major culprit in the induction of genome instability in <italic>tsa1</italic>&#x00394; cells. Indeed, reducing dNTP levels without affecting ROS production was sufficient to reverse the mutator phenotype of <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). In particular, <italic>tsa1</italic>&#x00394; <italic>dun1</italic>&#x00394; cells have high levels of ROS (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>), phosphorylated Rad53p (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>) and &#x003b3;H2A (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>). However, these cells showed a low mutation rate (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2C</xref>) because the dNTP levels were also low (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>). On the contrary, increasing dNTP levels by overexpressing <italic>RNR1</italic> aggravated the mutator phenotype (<xref ref-type="fig" rid="pgen-1000697-g004">Figure 4</xref>). Furthermore, point mutations but not deletions were predominantly found in <italic>tsa1</italic>&#x00394; cells (<xref ref-type="table" rid="pgen-1000697-t001">Table 1</xref>), implicating a role for dNTP overproduction in compromising genome stability. In further support of this model, compromise of TLS polymerases also suppressed CAN<sup>R</sup> mutations in <italic>tsa1</italic>&#x00394; cells <xref ref-type="bibr" rid="pgen.1000697-Ragu1">&#x0005b;23&#x0005d;</xref>.</p><p>We found that the levels of dNTPs in <italic>tsa1</italic>&#x00394; cells were as high as those in <italic>sml1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3A</xref>). This finding revealed an unexpected role of <italic>TSA1</italic> in the maintenance of dNTP pools in eukaryotic cells. We further observed transcriptional activation of <italic>RNR</italic> genes in <italic>tsa1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6</xref>), which could be mediated through the activation of Rad53p checkpoint. Although this might provide an explanation for the overproduction of dNTPs, exactly how Tsa1p is mechanistically involved in regulating <italic>RNR</italic> expression remains to be further investigated.</p><p>Consistent with previous findings <xref ref-type="bibr" rid="pgen.1000697-Chabes2">&#x0005b;26&#x0005d;</xref>, elevation of intracellular dNTPs over a particular threshold level by overexpressing Rnr1p can sufficiently induce a mutator phenotype (<xref ref-type="fig" rid="pgen-1000697-g004">Figure 4</xref>). Plausibly, the dNTP levels in <italic>tsa1</italic>&#x00394; <italic>sml1</italic>&#x00394; and <italic>tsa1</italic>&#x00394; <italic>crt1</italic>&#x00394; cells might have reached the threshold level causing a dramatically increased mutation rate (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref> and <xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). When the elevation of dNTP levels have not reached the threshold as in the case of <italic>sml1</italic>&#x00394;, <italic>crt1</italic>&#x00394; and <italic>tsa1</italic>&#x00394; cells, accumulation of intracellular ROS might serve to trigger or aggravate the mutator phenotype. In <italic>tsa1</italic>&#x00394; cells, ROS levels were constantly high (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>) causing severe DNA damage (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5</xref>). In contrast, ROS levels were low (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3C</xref>) and DNA damage was not detected (<xref ref-type="fig" rid="pgen-1000697-g005">Figure 5C</xref>) in <italic>sml1</italic>&#x00394; or <italic>crt1</italic>&#x00394; cells. This might explain the higher mutation rate in <italic>tsa1</italic>&#x00394; cells versus <italic>sml1</italic>&#x00394; or <italic>crt1</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2</xref>). Further exacerbation of the mutator phenotype of <italic>sml1</italic>&#x00394; and <italic>crt1</italic>&#x00394; cells by ROS such as H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="pgen-1000697-g002">Figure 2D</xref>) lent some credence to this model.</p><p>We demonstrated the requirement of the catalytic cysteine for the ability of Tsa1p to modulate dNTP production (<xref ref-type="fig" rid="pgen-1000697-g003">Figure 3</xref>). Through irreversible hyperoxidation, this residue can act as a redox sensor, which triggers the switch of peroxiredoxin from peroxidase to chaperone activity under stress <xref ref-type="bibr" rid="pgen.1000697-Lim1">&#x0005b;12&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Jang1">&#x0005b;13&#x0005d;</xref>. In this connection, it would be of great interest to understand whether and how the chaperone activity of Tsa1p might be involved in the regulation of dNTP production.</p><p>Activation of Rad53p by upstream kinase Mec1p requires adaptor proteins Rad9p and Mrc1p <xref ref-type="bibr" rid="pgen.1000697-Alcasabas1">&#x0005b;46&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Lee1">&#x0005b;47&#x0005d;</xref>. We noted that Rad53p phosphorylation was dramatically increased in <italic>tsa1</italic>&#x00394; versus WT cells (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6A</xref> and <xref ref-type="fig" rid="pgen-1000697-g007">Figure 7A</xref>). In contrast, the increase in Rad9p phosphorylation in the absence of <italic>TSA1</italic> was less pronounced (<xref ref-type="fig" rid="pgen-1000697-g006">Figure 6B</xref>). Although additional experiments are required to investigate the cause of this difference between Rad53p and Rad9p, one possibility is that the deletion of <italic>TSA1</italic> might exert a stronger effect on Mrc1p activity.</p><p>Hypermutability or genome instability is a hallmark of cancer <xref ref-type="bibr" rid="pgen.1000697-Loeb1">&#x0005b;48&#x0005d;</xref>. Mammalian <italic>Prx1</italic> is a candidate tumor suppressor gene <xref ref-type="bibr" rid="pgen.1000697-Neumann1">&#x0005b;15&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref>. Because peroxiredoxins are highly evolutionarily conserved proteins, an understanding of the mechanism by which yeast Tsa1p protects cell from genome instability might derive novel insight into the tumor suppressive role of Prx1 in mammalian cells. Our work demonstrates the importance of high dNTP levels in the mutability of <italic>tsa1</italic>&#x00394; cells. Further analysis of dNTP concentrations of Prx1-null mouse cells will reveal whether increased production of dNTPs might be a general mechanism for the generation of genome instability in higher eukaryotes.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Strains and Plasmids</title><p><italic>S. cerevisiae</italic> strains BY4741 <xref ref-type="bibr" rid="pgen.1000697-Winzeler1">&#x0005b;50&#x0005d;</xref> and W303-1a, and their isogenic strains (<xref ref-type="table" rid="pgen-1000697-t002">Table 2</xref>) were used. All knockout mutants were constructed by one-step gene deletion method <xref ref-type="bibr" rid="pgen.1000697-Longtine1">&#x0005b;51&#x0005d;</xref>. Primers were listed in <xref ref-type="table" rid="pgen-1000697-t003">Table 3</xref>. Expression vector for <italic>DUN1</italic> was derived from pRS415. Expression plasmids for <italic>TSA1</italic> and its mutants have been described <xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>.</p><table-wrap id="pgen-1000697-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.t002</object-id><label>Table 2</label><caption><title>Yeast strains.</title></caption><alternatives><graphic id="pgen-1000697-t002-2" xlink:href="pgen.1000697.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">name</td><td align="left" rowspan="1" colspan="1">parent</td><td align="left" rowspan="1" colspan="1">genotype</td><td align="left" rowspan="1" colspan="1">reference</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>MATa his3</italic>&#x00394;<italic>1 leu2</italic>&#x00394;<italic>0 met15</italic>&#x00394;<italic>0 ura3</italic>&#x00394;<italic>0</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HMY001</td><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"><italic>tsa1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">3798<xref ref-type="table-fn" rid="nt102">a</xref></td><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"><italic>dun1</italic>&#x00394;::<italic>KanMX4</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">512<xref ref-type="table-fn" rid="nt102">a</xref></td><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"><italic>sml1</italic>&#x00394;::<italic>KanMX4</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">4125<xref ref-type="table-fn" rid="nt102">a</xref></td><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"><italic>crt1</italic>&#x00394;::<italic>KanMX4</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">6913<xref ref-type="table-fn" rid="nt102">a</xref></td><td align="left" rowspan="1" colspan="1">BY4741</td><td align="left" rowspan="1" colspan="1"><italic>sod1</italic>&#x00394;::<italic>KanMX4</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HMY002</td><td align="left" rowspan="1" colspan="1">3798</td><td align="left" rowspan="1" colspan="1"><italic>dun1</italic>&#x00394;::<italic>KanMX4 tsa1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY003</td><td align="left" rowspan="1" colspan="1">512</td><td align="left" rowspan="1" colspan="1"><italic>sml1</italic>&#x00394;::<italic>KanMX4 tsa1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY004</td><td align="left" rowspan="1" colspan="1">4125</td><td align="left" rowspan="1" colspan="1"><italic>crt1</italic>&#x00394;::<italic>KanMX4 tsa1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY005</td><td align="left" rowspan="1" colspan="1">3798</td><td align="left" rowspan="1" colspan="1"><italic>dun1</italic>&#x00394;::<italic>KanMX4 sod1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY006</td><td align="left" rowspan="1" colspan="1">512</td><td align="left" rowspan="1" colspan="1"><italic>sml1</italic>&#x00394;::<italic>KanMX4 sod1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY007</td><td align="left" rowspan="1" colspan="1">4125</td><td align="left" rowspan="1" colspan="1"><italic>crt1</italic>&#x00394;::<italic>KanMX4 sod1</italic>&#x00394;::<italic>HIS3&#x0002a;</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY1001</td><td align="left" rowspan="1" colspan="1">HMY001</td><td align="left" rowspan="1" colspan="1"><italic>tsa1</italic>&#x00394;::<italic>HIS3&#x0002a; RAD9-13MYC</italic>::<italic>KanMX4</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">W303-1a</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><italic>MATa ade2 ura3 trp1 leu2 his3 can1</italic></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">cy7075</td><td align="left" rowspan="1" colspan="1">W303-1a</td><td align="left" rowspan="1" colspan="1"><italic>SML1-3HA</italic>::<italic>HIS</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">cy7096</td><td align="left" rowspan="1" colspan="1">cy7075</td><td align="left" rowspan="1" colspan="1"><italic>SML1-3HA</italic>::<italic>HIS rad53AA</italic>::<italic>KANMX4</italic></td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pgen.1000697-Fiorani1">&#x0005b;40&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">HMY008</td><td align="left" rowspan="1" colspan="1">cy7075</td><td align="left" rowspan="1" colspan="1"><italic>SML1-3HA</italic>::<italic>HIS tsa1</italic>&#x00394;::<italic>TRP1</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr><tr><td align="left" rowspan="1" colspan="1">HMY009</td><td align="left" rowspan="1" colspan="1">cy7096</td><td align="left" rowspan="1" colspan="1"><italic>SML1-3HA</italic>::<italic>HIS rad53AA</italic>::<italic>KANMX4 tsa1</italic>&#x00394;::<italic>TRP1</italic></td><td align="left" rowspan="1" colspan="1">This work</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label>a</label><p>Purchased from Research Genetics <xref ref-type="bibr" rid="pgen.1000697-Cao1">&#x0005b;49&#x0005d;</xref>.</p></fn><fn id="nt103"><p><italic>HIS3&#x0002a;</italic> designates the <italic>HIS3</italic> allele from <italic>Saccharomyces kluyveri</italic>.</p></fn><fn id="nt104"><p>cy7075 and cy7096 were gifts from Dr. Achille Pellicioli (FIRC Institute of Molecular Oncology Foundation, Milano, Italy).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pgen-1000697-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1000697.t003</object-id><label>Table 3</label><caption><title>Oligonucleotide sequences for RT&#x02013;PCR and site-directed mutagenesis.</title></caption><alternatives><graphic id="pgen-1000697-t003-3" xlink:href="pgen.1000697.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">name</td><td align="left" rowspan="1" colspan="1">sequence</td><td align="left" rowspan="1" colspan="1">expected size (bp)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">RNR1-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">ATTTCGTGCCCGCAGC</named-content></td><td align="left" rowspan="1" colspan="1">219</td></tr><tr><td align="left" rowspan="1" colspan="1">RNR1-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTCCTCATCA TCAACGATGGG</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RNR2-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">ATGCCTAAAGAGACCCCTTCCA</named-content></td><td align="left" rowspan="1" colspan="1">390</td></tr><tr><td align="left" rowspan="1" colspan="1">RNR2-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CTCGTTTTCGTTCATTCTGTTGTTC</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RNR3-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GGGTACAAAATTCTCTGAACAAA</named-content></td><td align="left" rowspan="1" colspan="1">199</td></tr><tr><td align="left" rowspan="1" colspan="1">RNR3-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AATGTCACAT TTCTTCTCGTCG</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">RNR4-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">ATGGAAGCACATAACCAATTT</named-content></td><td align="left" rowspan="1" colspan="1">455</td></tr><tr><td align="left" rowspan="1" colspan="1">RNR4-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCAATTTCCTTGAATAGAGGGA</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ACT1-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CACCCTGTTC TTTTGACTGAAGC</named-content></td><td align="left" rowspan="1" colspan="1">520</td></tr><tr><td align="left" rowspan="1" colspan="1">ACT1-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TACCGGCAGATTCCAAACCC</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HUG1-RT-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CCTTAACCCAAAGCAATTCTTCC</named-content></td><td align="left" rowspan="1" colspan="1">190</td></tr><tr><td align="left" rowspan="1" colspan="1">HUG1-RT-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TTAGTTGGAAGTATTCTTACCAATGTC</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TSA1-C47S-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CCATTGGCCT TCACTTTCGTCT(C)TCCAACCGAAATCATTG</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TSA1-C47S-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CAATGATTTCGGTTGGA(G)AGACGAAAGTGAAGGCCAATGG</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TSA1-C170S-F</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGAACGGTACTGTCTTGCCAT(C)TAACTGGACTCCAGGTGC</named-content></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TSA1-C170S-R</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">GCACCTGGAGTCCAGTTA(G)ATGGCAAGACAGTACCGTTCT</named-content></td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><p>The nucleotides to be changed are parenthesized.</p></fn></table-wrap-foot></table-wrap><p>Plasmid pGal-RNR1 kindly provided by Dr. Stephen Elledge has also been described previously <xref ref-type="bibr" rid="pgen.1000697-Huang4">&#x0005b;52&#x0005d;</xref>.</p></sec><sec id="s4b"><title>Measurement of Mutation Rates, dNTP, and ROS Levels</title><p>Rates of spontaneous forward mutations to confer CAN<sup>R</sup> or 5FC<sup>R</sup> were measured as described <xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Lis1">&#x0005b;53&#x0005d;</xref>. Spectra of CAN<sup>R</sup> mutations were determined by DNA sequencing. Ten independent cultures were analyzed in each experiment. Cell extracts were prepared and dNTP levels were measured with Klenow enzyme and &#x0005b;<sup>3</sup>H&#x0005d; labeled dATP or dTTP (PerkinElmer) as described <xref ref-type="bibr" rid="pgen.1000697-North1">&#x0005b;54&#x0005d;</xref>. Standard curves were used to estimate the cellular dNTP levels. Three independent cultures were analyzed in each experiment. Intracellular ROS levels were measured by fluorimetry using DCF (Molecular Probes) as described <xref ref-type="bibr" rid="pgen.1000697-Wong1">&#x0005b;4&#x0005d;</xref>,<xref ref-type="bibr" rid="pgen.1000697-Wong2">&#x0005b;18&#x0005d;</xref>.</p></sec><sec id="s4c"><title>RNA Analysis</title><p>Total RNA was extracted by phenol/freeze RNA preparation method as described <xref ref-type="bibr" rid="pgen.1000697-Schmitt1">&#x0005b;55&#x0005d;</xref>. For RT-PCR, 3 &#x000b5;g of total RNA was used for cDNA synthesis. Semi-quantitative PCR was performed and optimized to ensure that the amplification was in the linear range. PCR primers were listed in <xref ref-type="table" rid="pgen-1000697-t003">Table 3</xref>.</p></sec><sec id="s4d"><title>Western Blotting</title><p>Western blot analysis was performed essentially as described <xref ref-type="bibr" rid="pgen.1000697-Carter1">&#x0005b;31&#x0005d;</xref>. Yeast cells were harvested by centrifugation, followed by trichloroacetic acid extraction with the help of glass beads.</p></sec></sec></body><back><ack><p>We thank Drs. Stephen Elledge, Mark Longtine, and Achille Pellicioli for reagents; Dr. Christopher Mathews for advice in dNTP measurement; and members of Jin laboratory for critical reading of manuscript.</p></ack><ref-list><title>References</title><ref id="pgen.1000697-Rhee1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>SG</given-names></name><name><surname>Chae</surname><given-names>HZ</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.</article-title><source>Free Radic Biol Med</source><volume>38</volume><fpage>1543</fpage><lpage>1552</lpage><pub-id pub-id-type="pmid">15917183</pub-id></mixed-citation></ref><ref id="pgen.1000697-Fourquet1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourquet</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>ME</given-names></name><name><surname>D'Autreaux</surname><given-names>B</given-names></name><name><surname>Toledano</surname><given-names>MB</given-names></name></person-group><year>2008</year><article-title>The dual functions of thiol-based peroxidases in H<sub>2</sub>O<sub>2</sub> scavenging and signaling.</article-title><source>Antioxid Redox Signal</source><volume>10</volume><fpage>1565</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">18498222</pub-id></mixed-citation></ref><ref id="pgen.1000697-Bryk1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryk</surname><given-names>R</given-names></name><name><surname>Griffin</surname><given-names>P</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name></person-group><year>2000</year><article-title>Peroxynitrite reductase activity of bacterial peroxiredoxins.</article-title><source>Nature</source><volume>407</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">11001062</pub-id></mixed-citation></ref><ref id="pgen.1000697-Wong1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CM</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>RWM</given-names></name><name><surname>Kung</surname><given-names>HF</given-names></name><name><surname>Jin</surname><given-names>DY</given-names></name></person-group><year>2002</year><article-title>Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>5385</fpage><lpage>5394</lpage><pub-id pub-id-type="pmid">11741925</pub-id></mixed-citation></ref><ref id="pgen.1000697-Jin1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>DY</given-names></name><name><surname>Chae</surname><given-names>HZ</given-names></name><name><surname>Rhee</surname><given-names>SG</given-names></name><name><surname>Jeang</surname><given-names>KT</given-names></name></person-group><year>1997</year><article-title>Regulatory role for a novel human thioredoxin peroxidase in NF-&#x003ba;B activation.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>30952</fpage><lpage>30961</lpage><pub-id pub-id-type="pmid">9388242</pub-id></mixed-citation></ref><ref id="pgen.1000697-Delaunay1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaunay</surname><given-names>A</given-names></name><name><surname>Pflieger</surname><given-names>D</given-names></name><name><surname>Barrault</surname><given-names>MB</given-names></name><name><surname>Vinh</surname><given-names>J</given-names></name><name><surname>Toledano</surname><given-names>MB</given-names></name></person-group><year>2002</year><article-title>A thiol peroxidase is an H<sub>2</sub>O<sub>2</sub> receptor and redox-transducer in gene activation.</article-title><source>Cell</source><volume>111</volume><fpage>471</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">12437921</pub-id></mixed-citation></ref><ref id="pgen.1000697-Biteau1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biteau</surname><given-names>B</given-names></name><name><surname>Labarre</surname><given-names>J</given-names></name><name><surname>Toledano</surname><given-names>MB</given-names></name></person-group><year>2003</year><article-title>ATP-dependent reduction of cysteine-sulphinic acid by <italic>S. cerevisiae</italic> sulphiredoxin.</article-title><source>Nature</source><volume>425</volume><fpage>980</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">14586471</pub-id></mixed-citation></ref><ref id="pgen.1000697-Woo1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>HA</given-names></name><name><surname>Chae</surname><given-names>HZ</given-names></name><name><surname>Hwang</surname><given-names>SC</given-names></name><name><surname>Yang</surname><given-names>KS</given-names></name><name><surname>Kang</surname><given-names>SW</given-names></name><etal/></person-group><year>2003</year><article-title>Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation.</article-title><source>Science</source><volume>300</volume><fpage>653</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">12714748</pub-id></mixed-citation></ref><ref id="pgen.1000697-Wood1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>ZA</given-names></name><name><surname>Poole</surname><given-names>LB</given-names></name><name><surname>Karplus</surname><given-names>PA</given-names></name></person-group><year>2003</year><article-title>Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling.</article-title><source>Science</source><volume>300</volume><fpage>650</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">12714747</pub-id></mixed-citation></ref><ref id="pgen.1000697-Veal1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veal</surname><given-names>EA</given-names></name><name><surname>Findlay</surname><given-names>VJ</given-names></name><name><surname>Day</surname><given-names>AM</given-names></name><name><surname>Bozonet</surname><given-names>SM</given-names></name><name><surname>Evans</surname><given-names>JM</given-names></name><etal/></person-group><year>2004</year><article-title>A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase.</article-title><source>Mol Cell</source><volume>15</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">15225554</pub-id></mixed-citation></ref><ref id="pgen.1000697-Choi1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>IK</given-names></name><name><surname>Kim</surname><given-names>GW</given-names></name><name><surname>Kim</surname><given-names>BU</given-names></name><name><surname>Han</surname><given-names>YH</given-names></name><etal/></person-group><year>2005</year><article-title>Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II.</article-title><source>Nature</source><volume>435</volume><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">15902258</pub-id></mixed-citation></ref><ref id="pgen.1000697-Lim1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JC</given-names></name><name><surname>Choi</surname><given-names>HI</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Nam</surname><given-names>HW</given-names></name><name><surname>Woo</surname><given-names>HA</given-names></name><etal/></person-group><year>2008</year><article-title>Irreversible oxidation of the active-site cysteine of peroxiredoxin to cysteine sulfonic acid for enhanced molecular chaperone activity.</article-title><source>J Biol Chem</source><volume>283</volume><fpage>28873</fpage><lpage>28880</lpage><pub-id pub-id-type="pmid">18725414</pub-id></mixed-citation></ref><ref id="pgen.1000697-Jang1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>KO</given-names></name><name><surname>Chi</surname><given-names>YH</given-names></name><name><surname>Jung</surname><given-names>BG</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><etal/></person-group><year>2004</year><article-title>Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function.</article-title><source>Cell</source><volume>117</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">15163410</pub-id></mixed-citation></ref><ref id="pgen.1000697-Kmin1"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000fc;min</surname><given-names>A</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>M</given-names></name><name><surname>Epp</surname><given-names>N</given-names></name><name><surname>Bugnon</surname><given-names>P</given-names></name><name><surname>Born-Berclaz</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>Peroxiredoxin 6 is required for blood vessel integrity in wounded skin.</article-title><source>J Cell Biol</source><volume>179</volume><fpage>747</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">18025307</pub-id></mixed-citation></ref><ref id="pgen.1000697-Neumann1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>CA</given-names></name><name><surname>HKrause</surname><given-names>DSH</given-names></name><name><surname>HCarman</surname><given-names>CVH</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>HDubey</surname><given-names>DPH</given-names></name><etal/></person-group><year>2003</year><article-title>Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression.</article-title><source>Nature</source><volume>424</volume><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">12891360</pub-id></mixed-citation></ref><ref id="pgen.1000697-Huang1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ME</given-names></name><name><surname>Rio</surname><given-names>AG</given-names></name><name><surname>Nicolas</surname><given-names>A</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name></person-group><year>2003</year><article-title>A genomewide screen in <italic>Saccharomyces cerevisiae</italic> for genes that suppress the accumulation of mutations.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>11529</fpage><lpage>11534</lpage><pub-id pub-id-type="pmid">12972632</pub-id></mixed-citation></ref><ref id="pgen.1000697-Smith1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Hwang</surname><given-names>JY</given-names></name><name><surname>HBanerjee</surname><given-names>SH</given-names></name><name><surname>HMajeed</surname><given-names>AH</given-names></name><name><surname>HGupta</surname><given-names>AH</given-names></name><etal/></person-group><year>2004</year><article-title>Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Proc Natl Acad Sci U S A</source><volume>101</volume><fpage>9039</fpage><lpage>9044</lpage><pub-id pub-id-type="pmid">15184655</pub-id></mixed-citation></ref><ref id="pgen.1000697-Wong2"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CM</given-names></name><name><surname>Siu</surname><given-names>KL</given-names></name><name><surname>Jin</surname><given-names>DY</given-names></name></person-group><year>2004</year><article-title>Peroxiredoxin-null yeast cells are hypersensitive to oxidative stress and are genomically unstable.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>23207</fpage><lpage>23213</lpage><pub-id pub-id-type="pmid">15051715</pub-id></mixed-citation></ref><ref id="pgen.1000697-Iraqui1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Faye</surname><given-names>G</given-names></name><name><surname>Ragu</surname><given-names>S</given-names></name><name><surname>Masurel-Heneman</surname><given-names>A</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name><etal/></person-group><year>2008</year><article-title>Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Cancer Res</source><volume>68</volume><fpage>1055</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">18281480</pub-id></mixed-citation></ref><ref id="pgen.1000697-Tong1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>AH</given-names></name><name><surname>Lesage</surname><given-names>G</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><etal/></person-group><year>2004</year><article-title>Global mapping of the yeast genetic interaction network.</article-title><source>Science</source><volume>303</volume><fpage>808</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">14764870</pub-id></mixed-citation></ref><ref id="pgen.1000697-Pan1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>P</given-names></name><name><surname>Yuan</surname><given-names>DS</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Bader</surname><given-names>JS</given-names></name><etal/></person-group><year>2006</year><article-title>A DNA integrity network in the yeast <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Cell</source><volume>124</volume><fpage>1069</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">16487579</pub-id></mixed-citation></ref><ref id="pgen.1000697-Huang2"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>ME</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name></person-group><year>2005</year><article-title>A biological network in <italic>Saccharomyces cerevisiae</italic> prevents the deleterious effects of endogenous oxidative DNA damage.</article-title><source>Mol Cell</source><volume>17</volume><fpage>709</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">15749020</pub-id></mixed-citation></ref><ref id="pgen.1000697-Ragu1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragu</surname><given-names>S</given-names></name><name><surname>Faye</surname><given-names>G</given-names></name><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Masurel-Heneman</surname><given-names>A</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name><etal/></person-group><year>2007</year><article-title>Oxygen metabolism and reactive oxygen species cause chromosomal rearrangements and cell death.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>9747</fpage><lpage>9752</lpage><pub-id pub-id-type="pmid">17535927</pub-id></mixed-citation></ref><ref id="pgen.1000697-Chabes1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabes</surname><given-names>A</given-names></name><name><surname>Georgieva</surname><given-names>B</given-names></name><name><surname>Domkin</surname><given-names>V</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name><etal/></person-group><year>2003</year><article-title>Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase.</article-title><source>Cell</source><volume>112</volume><fpage>391</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">12581528</pub-id></mixed-citation></ref><ref id="pgen.1000697-Sabouri1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabouri</surname><given-names>N</given-names></name><name><surname>Viberg</surname><given-names>J</given-names></name><name><surname>Goyal</surname><given-names>DK</given-names></name><name><surname>Johansson</surname><given-names>E</given-names></name><name><surname>Chabes</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage.</article-title><source>Nucleic Acids Res</source><volume>36</volume><fpage>5660</fpage><lpage>5667</lpage><pub-id pub-id-type="pmid">18772226</pub-id></mixed-citation></ref><ref id="pgen.1000697-Chabes2"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabes</surname><given-names>A</given-names></name><name><surname>Stillman</surname><given-names>B</given-names></name></person-group><year>2007</year><article-title>Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>1183</fpage><lpage>1188</lpage><pub-id pub-id-type="pmid">17227840</pub-id></mixed-citation></ref><ref id="pgen.1000697-Ogusucu1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogusucu</surname><given-names>R</given-names></name><name><surname>Rettori</surname><given-names>D</given-names></name><name><surname>Netto</surname><given-names>LE</given-names></name><name><surname>Augusto</surname><given-names>O</given-names></name></person-group><year>2009</year><article-title>Superoxide dismutase 1-mediated production of ethanol- and DNA-derived radicals in yeasts challenged with hydrogen peroxide: Molecular insights into the genome instability of peroxiredoxin-null strains.</article-title><source>J Biol Chem</source><volume>284</volume><fpage>5546</fpage><lpage>5556</lpage><pub-id pub-id-type="pmid">19106092</pub-id></mixed-citation></ref><ref id="pgen.1000697-Zhao1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name></person-group><year>2002</year><article-title>The Dun1 checkpoint kinase phosphorylates and regulates the ribonucleotide reductase inhibitor Sml1.</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>3746</fpage><lpage>3751</lpage><pub-id pub-id-type="pmid">11904430</pub-id></mixed-citation></ref><ref id="pgen.1000697-Huang3"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><year>1998</year><article-title>The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor.</article-title><source>Cell</source><volume>94</volume><fpage>595</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">9741624</pub-id></mixed-citation></ref><ref id="pgen.1000697-Zaim1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaim</surname><given-names>J</given-names></name><name><surname>Speina</surname><given-names>E</given-names></name><name><surname>Kierzek</surname><given-names>AM</given-names></name></person-group><year>2005</year><article-title>Identification of new genes regulated by the Crt1 transcription factor, an effector of the DNA damage checkpoint pathway in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">15494396</pub-id></mixed-citation></ref><ref id="pgen.1000697-Carter1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CD</given-names></name><name><surname>Kitchen</surname><given-names>LE</given-names></name><name><surname>Au</surname><given-names>WC</given-names></name><name><surname>Babic</surname><given-names>CM</given-names></name><name><surname>Basrai</surname><given-names>MA</given-names></name></person-group><year>2005</year><article-title>Loss of <italic>SOD1</italic> and <italic>LYS7</italic> sensitizes <italic>Saccharomyces cerevisiae</italic> to hydroxyurea and DNA damage agents and downregulates <italic>MEC1</italic> pathway effectors.</article-title><source>Mol Cell Biol</source><volume>25</volume><fpage>10273</fpage><lpage>10285</lpage><pub-id pub-id-type="pmid">16287844</pub-id></mixed-citation></ref><ref id="pgen.1000697-Elledge1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elledge</surname><given-names>SJ</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Allen</surname><given-names>JB</given-names></name><name><surname>Navas</surname><given-names>TA</given-names></name></person-group><year>1993</year><article-title>DNA damage and cell cycle regulation of ribonucleotide reductase.</article-title><source>Bioessays</source><volume>15</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">8343143</pub-id></mixed-citation></ref><ref id="pgen.1000697-Gon1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon</surname><given-names>S</given-names></name><name><surname>Beckwith</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>Ribonucleotide reductases: influence of environment on synthesis and activity.</article-title><source>Antioxid Redox Signal</source><volume>8</volume><fpage>773</fpage><lpage>780</lpage><pub-id pub-id-type="pmid">16771669</pub-id></mixed-citation></ref><ref id="pgen.1000697-Nordlund1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname><given-names>P</given-names></name><name><surname>Reichard</surname><given-names>P</given-names></name></person-group><year>2006</year><article-title>Ribonucleotide reductases.</article-title><source>Annu Rev Biochem</source><volume>75</volume><fpage>681</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">16756507</pub-id></mixed-citation></ref><ref id="pgen.1000697-Sanchez1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>Y</given-names></name><name><surname>Desany</surname><given-names>BA</given-names></name><name><surname>Jones</surname><given-names>WJ</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><year>1996</year><article-title>Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways.</article-title><source>Science</source><volume>271</volume><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">8553072</pub-id></mixed-citation></ref><ref id="pgen.1000697-Pellicioli1"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellicioli</surname><given-names>A</given-names></name><name><surname>Lucca</surname><given-names>C</given-names></name><name><surname>Liberi</surname><given-names>G</given-names></name><name><surname>Marini</surname><given-names>F</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>Activation of Rad53 kinase in response to DNA damage and its effect in modulating phosphorylation of the lagging strand DNA polymerase.</article-title><source>EMBO J</source><volume>18</volume><fpage>6561</fpage><lpage>6572</lpage><pub-id pub-id-type="pmid">10562568</pub-id></mixed-citation></ref><ref id="pgen.1000697-Sweeney1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname><given-names>FD</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chi</surname><given-names>A</given-names></name><name><surname>Shabanowitz</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>DF</given-names></name><etal/></person-group><year>2005</year><article-title><italic>Saccharomyces cerevisiae</italic> Rad9 acts as a Mec1 adaptor to allow Rad53 activation.</article-title><source>Curr Biol</source><volume>15</volume><fpage>1364</fpage><lpage>1375</lpage><pub-id pub-id-type="pmid">16085488</pub-id></mixed-citation></ref><ref id="pgen.1000697-Fillingham1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillingham</surname><given-names>J</given-names></name><name><surname>Keogh</surname><given-names>MC</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name></person-group><year>2006</year><article-title>&#x003b3;H2AX and its role in DNA double-strand break repair.</article-title><source>Biochem Cell Biol</source><volume>84</volume><fpage>568</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">16936829</pub-id></mixed-citation></ref><ref id="pgen.1000697-Basrai1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basrai</surname><given-names>MA</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Hieter</surname><given-names>P</given-names></name></person-group><year>1999</year><article-title>NORF5/HUG1 is a component of the MEC1-mediated checkpoint response to DNA damage and replication arrest in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Mol Cell Biol</source><volume>19</volume><fpage>7041</fpage><lpage>7049</lpage><pub-id pub-id-type="pmid">10490641</pub-id></mixed-citation></ref><ref id="pgen.1000697-Fiorani1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiorani</surname><given-names>S</given-names></name><name><surname>Mimun</surname><given-names>G</given-names></name><name><surname>Caleca</surname><given-names>L</given-names></name><name><surname>Piccini</surname><given-names>D</given-names></name><name><surname>Pellicioli</surname><given-names>A</given-names></name></person-group><year>2008</year><article-title>Characterization of the activation domain of the Rad53 checkpoint kinase.</article-title><source>Cell Cycle</source><volume>7</volume><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">18287812</pub-id></mixed-citation></ref><ref id="pgen.1000697-Koc1"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koc</surname><given-names>A</given-names></name><name><surname>Merrill</surname><given-names>GF</given-names></name></person-group><year>2007</year><article-title>Checkpoint deficient rad53-11 yeast cannot accumulate dNTPs in response to DNA damage.</article-title><source>Biochem Biophys Res Commun</source><volume>353</volume><fpage>527</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">17188244</pub-id></mixed-citation></ref><ref id="pgen.1000697-Beckman1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>KB</given-names></name><name><surname>Ames</surname><given-names>BN</given-names></name></person-group><year>1997</year><article-title>Oxidative decay of DNA.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>19633</fpage><lpage>19636</lpage><pub-id pub-id-type="pmid">9289489</pub-id></mixed-citation></ref><ref id="pgen.1000697-Finkel1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>T</given-names></name><name><surname>Holbrook</surname><given-names>NJ</given-names></name></person-group><year>2000</year><article-title>Oxidants, oxidative stress and the biology of ageing.</article-title><source>Nature</source><volume>408</volume><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">11089981</pub-id></mixed-citation></ref><ref id="pgen.1000697-Iraqui2"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Kienda</surname><given-names>G</given-names></name><name><surname>Soeur</surname><given-names>J</given-names></name><name><surname>Faye</surname><given-names>G</given-names></name><name><surname>Baldacci</surname><given-names>G</given-names></name><etal/></person-group><year>2009</year><article-title>Peroxiredoxin Tsa1 is the key peroxidase suppressing genome instability and protecting against cell death in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>PLoS Genet</source><volume>5</volume><fpage>e1000524</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000524">10.1371/journal.pgen.1000524</ext-link></comment><pub-id pub-id-type="pmid">19543365</pub-id></mixed-citation></ref><ref id="pgen.1000697-Graves1"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>JA</given-names></name><name><surname>Metukuri</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>D</given-names></name><name><surname>Rothermund</surname><given-names>K</given-names></name><name><surname>Prochownik</surname><given-names>EV</given-names></name></person-group><year>2009</year><article-title>Regulation of reactive oxygen species homeostasis by peroxiredoxins and c-Myc.</article-title><source>J Biol Chem</source><volume>284</volume><fpage>6520</fpage><lpage>6529</lpage><pub-id pub-id-type="pmid">19098005</pub-id></mixed-citation></ref><ref id="pgen.1000697-Alcasabas1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcasabas</surname><given-names>AA</given-names></name><name><surname>Osborn</surname><given-names>AJ</given-names></name><name><surname>Bachant</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>F</given-names></name><name><surname>Werler</surname><given-names>PJ</given-names></name><etal/></person-group><year>2001</year><article-title>Mrc1 transduces signals of DNA replication stress to activate Rad53.</article-title><source>Nat Cell Biol</source><volume>3</volume><fpage>958</fpage><lpage>965</lpage><pub-id pub-id-type="pmid">11715016</pub-id></mixed-citation></ref><ref id="pgen.1000697-Lee1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Duong</surname><given-names>JK</given-names></name><name><surname>Stern</surname><given-names>DF</given-names></name></person-group><year>2004</year><article-title>A Ddc2-Rad53 fusion protein can bypass the requirements for RAD9 and MRC1 in Rad53 activation.</article-title><source>Mol Biol Cell</source><volume>15</volume><fpage>5443</fpage><lpage>5455</lpage><pub-id pub-id-type="pmid">15456903</pub-id></mixed-citation></ref><ref id="pgen.1000697-Loeb1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeb</surname><given-names>LA</given-names></name><name><surname>Bielas</surname><given-names>JH</given-names></name><name><surname>Beckman</surname><given-names>RA</given-names></name></person-group><year>2008</year><article-title>Cancers exhibit a mutator phenotype: clinical implications.</article-title><source>Cancer Res</source><volume>68</volume><fpage>3551</fpage><lpage>3557</lpage><pub-id pub-id-type="pmid">18483233</pub-id></mixed-citation></ref><ref id="pgen.1000697-Cao1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Schulte</surname><given-names>J</given-names></name><name><surname>Knight</surname><given-names>A</given-names></name><name><surname>Leslie</surname><given-names>NR</given-names></name><name><surname>Zagozdzon</surname><given-names>A</given-names></name><etal/></person-group><year>2009</year><article-title>Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.</article-title><source>EMBO J</source><volume>28</volume><fpage>1505</fpage><lpage>1517</lpage><pub-id pub-id-type="pmid">19369943</pub-id></mixed-citation></ref><ref id="pgen.1000697-Winzeler1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winzeler</surname><given-names>EA</given-names></name><name><surname>Shoemaker</surname><given-names>DD</given-names></name><name><surname>Astromoff</surname><given-names>A</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>Functional characterization of the <italic>S. cerevisiae</italic> genome by gene deletion and parallel analysis.</article-title><source>Science</source><volume>285</volume><fpage>901</fpage><lpage>906</lpage><pub-id pub-id-type="pmid">10436161</pub-id></mixed-citation></ref><ref id="pgen.1000697-Longtine1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longtine</surname><given-names>MS</given-names></name><name><surname>McKenzie</surname><given-names>A</given-names><suffix>3rd</suffix></name><name><surname>Demarini</surname><given-names>DJ</given-names></name><name><surname>Shah</surname><given-names>NG</given-names></name><name><surname>Wach</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><article-title>Additional modules for versatile and economical PCR-based gene deletion and modification in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Yeast</source><volume>14</volume><fpage>953</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">9717241</pub-id></mixed-citation></ref><ref id="pgen.1000697-Huang4"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><year>1997</year><article-title>Identification of <italic>RNR4</italic>, encoding a second essential small subunit of ribonucleotide reductase in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Mol Cell Biol</source><volume>17</volume><fpage>6105</fpage><lpage>6113</lpage><pub-id pub-id-type="pmid">9315670</pub-id></mixed-citation></ref><ref id="pgen.1000697-Lis1"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lis</surname><given-names>ET</given-names></name><name><surname>O'Neill</surname><given-names>BM</given-names></name><name><surname>Gil-Lamaignere</surname><given-names>C</given-names></name><name><surname>Chin</surname><given-names>JK</given-names></name><name><surname>Romesberg</surname><given-names>FE</given-names></name></person-group><year>2008</year><article-title>Identification of pathways controlling DNA damage induced mutation in <italic>Saccharomyces cerevisiae</italic>.</article-title><source>DNA Repair</source><volume>7</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">18400565</pub-id></mixed-citation></ref><ref id="pgen.1000697-North1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>TW</given-names></name><name><surname>Bestwick</surname><given-names>RK</given-names></name><name><surname>Mathews</surname><given-names>CK</given-names></name></person-group><year>1980</year><article-title>Detection of activities that interfere with the enzymatic assay of deoxyribonucleoside 5&#x02032;-triphosphates.</article-title><source>J Biol Chem</source><volume>255</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="pmid">6248528</pub-id></mixed-citation></ref><ref id="pgen.1000697-Schmitt1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>ME</given-names></name><name><surname>Brown</surname><given-names>TA</given-names></name><name><surname>Trumpower</surname><given-names>BL</given-names></name></person-group><year>1990</year><article-title>A rapid and simple method for preparation of RNA from <italic>Saccharomyces cerevisiae</italic>.</article-title><source>Nucleic Acids Res</source><volume>18</volume><fpage>3091</fpage><lpage>3092</lpage><pub-id pub-id-type="pmid">2190191</pub-id></mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This work is supported by Hong Kong Research Grants Council (projects HKU7340/03M and HKU7670/07M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article>